日水製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4550/E00971 | Nissui Pharmaceutical Co., Ltd |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2021/10/29 | 日証協 | 13,940株 | +44.61% | 13,000株 | +2500% | 119,284株 | 0% | 3,702株 | +146.64% |
2021/10/22 | 日証協 | 9,640株 | -26.07% | 500株 | -89.36% | 119,284株 | -0.08% | 1,501株 | -84.37% |
2021/10/15 | 日証協 | 13,040株 | -83.98% | 4,700株 | -76.89% | 119,382株 | +5.57% | 9,601株 | -36.84% |
2021/10/08 | 日証協 | 81,400株 | -16.89% | 20,340株 | -76.1% | 113,082株 | -10.1% | 15,200株 | -78.27% |
2021/10/01 | 日証協 | 97,943株 | +458.3% | 85,100株 | +463.58% | 125,781株 | +8.17% | 69,943株 | -28.77% |
2021/09/24 | 日証協 | 17,543株 | -84.09% | 15,100株 | +55.67% | 116,282株 | -4.44% | 98,200株 | +2183.72% |
2021/09/17 | 日証協 | 110,243株 | +3.28% | 9,700株 | -90.51% | 121,682株 | +1.49% | 4,300株 | -10.42% |
2021/09/10 | 日証協 | 106,743株 | +841.05% | 102,200株 | 0% | 119,892株 | -0.91% | 4,800株 | +66.49% |
2021/09/03 | 日証協 | 11,343株 | -6.59% | 0株 | -100% | 120,992株 | -0.08% | 2,883株 | +78.74% |
2021/08/27 | 日証協 | 12,143株 | +4.68% | 5,500株 | -9.84% | 121,092株 | -0.16% | 1,613株 | -41.54% |
2021/08/20 | 日証協 | 11,600株 | +7.41% | 6,100株 | -37.48% | 121,292株 | -2.1% | 2,759株 | +29.47% |
2021/08/13 | 日証協 | 10,800株 | -8.03% | 9,757株 | +45.63% | 123,892株 | -0.96% | 2,131株 | -36.9% |
2021/08/06 | 日証協 | 11,743株 | +29.04% | 6,700株 | +63.41% | 125,092株 | +4.09% | 3,377株 | -35.39% |
2021/07/30 | 日証協 | 9,100株 | -9.9% | 4,100株 | +378.41% | 120,181株 | -5.13% | 5,227株 | +444.48% |
2021/07/21 | 日証協 | 10,100株 | +4.74% | 857株 | -78.03% | 126,681株 | +0.4% | 960株 | -41.39% |
2021/07/16 | 日証協 | 9,643株 | -20.59% | 3,900株 | +680% | 126,180株 | -1.98% | 1,638株 | -39.78% |
2021/07/09 | 日証協 | 12,143株 | -49.07% | 500株 | -87.18% | 128,725株 | -0.31% | 2,720株 | -84.94% |
2021/07/02 | 日証協 | 23,843株 | +3.02% | 3,900株 | -36.51% | 129,125株 | +4.79% | 18,065株 | +539.02% |
2021/06/25 | 日証協 | 23,143株 | +9.68% | 6,143株 | +57.51% | 123,225株 | -2.92% | 2,827株 | -19.87% |
※株式分割は考慮していませんのでご注意ください。